AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Bdtofa Tablet

Prescription Icon
Prescription Required

Marketer

BDR Pharmaceuticals Internationals Pvt

Salt Composition

Tofacitinib (5mg)

Overview Bdtofa Tablet

Arthrocin tablets are indicated for managing moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. They alleviate joint pain, tenderness, and swelling by suppressing inflammation and help retard the progression of joint and bone deterioration. Arthrocin may be administered alone or in conjunction with other medications. These tablets can be ingested with or without food, ideally at the same time daily. Dosage is determined by your medical condition and concurrent medications, always following your physician's instructions. Discontinue use only under your doctor's guidance, as premature cessation may exacerbate your condition. Common adverse effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, side effects such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Consult your doctor regarding any concerns about side effects. Pre-treatment blood work may be required, and initiation of therapy is contraindicated in the presence of infection. Inform your doctor before commencing treatment if you have, or have previously had, tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. Arthrocin can increase susceptibility to infections or worsen existing ones; therefore, minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, rubeola, influenza). This medication is unsuitable for individuals under 18 years of age and should not be used during pregnancy or lactation unless the potential benefits outweigh the risks, as assessed by your doctor. Regular monitoring by your physician may be necessary.

Primary Ingredients of Bdtofa Tablet

The information is unavailable.

Uses of Bdtofa Tablet

Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.

Major Benefits of Bdtofa Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bdtofa Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Bdtofa Tablet:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use Bdtofa Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bdtofa Tablets can be consumed with or without food, though consistent timing is recommended.

How Bdtofa Tablet works:

Janus kinase activity is inhibited by Bdtofa Tablets. This mechanism suppresses immune system activation and reduces inflammation characteristic of rheumatic disorders and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse interactions between Bdtofa Tablet and alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Bdtofa Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Bdtofa Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Bdtofa Tablet.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using Bdtofa Tablet. A modified dosage of Bdtofa Tablet may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Bdtofa Tablet. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Bdtofa Tablet :

Should you forget a Bdtofa Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Bdtofa Tablet

LabelValue
Type of Compound Pyrrolopyrimidine compound
Potential for Dependence None.
Type of Medication Pain relievers
Mechanism of Action Kinase inhibitors targeting Janus kinases

FAQs on Bdtofa Tablet

Patients with liver disease should consult their physician prior to commencing Bdtofa Tablet therapy. This precaution is necessary as Bdtofa Tablet may, in certain instances, elevate liver enzyme levels. Consequently, assessment of hepatic function is recommended before initiating treatment. While Bdtofa Tablet may be administered to individuals with mild to moderate hepatic impairment, its use is contraindicated in patients exhibiting severe liver dysfunction.
Taking Bdtofa Tablet could heighten the likelihood of specific cancers (such as lymphoma and various skin cancers) due to its impact on the immune system. Therefore, disclose any history of cancer to your physician.
Bdtofa Tablet is indicated for adults with moderate to severe rheumatoid arthritis, a joint inflammatory condition. Its use is appropriate when prior treatments have proven ineffective or unsuitable. Alternatively, it may be employed earlier in the treatment course if initial medications yield unsatisfactory results. Bdtofa Tablet can be administered as monotherapy or in conjunction with other medications, including methotrexate.
The typical onset of noticeable improvement with Bdtofa Tablets is between two and eight weeks; however, achieving the medication's full therapeutic benefit may require three to six months.
Prior to commencing or during treatment with Bdtofa Tablet, blood work may be necessary. These tests assess for anemia (low red blood cell count), neutropenia or lymphopenia (low white blood cell count), elevated cholesterol (high blood fat), and increased liver enzyme levels. This monitoring helps determine if Bdtofa Tablet is causing adverse effects. Furthermore, pre-treatment tuberculosis screening might be recommended by your physician, since Bdtofa Tablet use could potentially exacerbate a pre-existing infection.
Bdtofa Tablets modulate the immune system, potentially impairing the body's defense against infection and raising the risk of severe illness, such as tuberculosis. This increased susceptibility extends to systemic fungal, bacterial, or viral infections. Such infections can be life-threatening and fatal; therefore, hospitalization for their treatment is recommended.
Concurrent use of tocilizumab and Bdtofa Tablet is contraindicated. Bdtofa Tablet's immunosuppressive properties necessitate avoiding concomitant administration with other medications impacting the immune system. Combined use elevates the infection risk and may result in additional adverse effects.
Bdtofa Tablet
295
MRP 360
18% off